Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274.
Title: | Adjuvant Nivolumab in High-Risk Muscle-Invasive Urothelial Carcinoma: Expanded Efficacy From CheckMate 274. |
---|---|
Authors: | Galsky, Matthew D., Witjes, Johannes Alfred, Gschwend, Jürgen E., Milowsky, Matthew I., Schenker, Michael, Valderrama, Begoña P., Tomita, Yoshihiko, Bamias, Aristotelis, Lebret, Thierry, Shariat, Shahrokh F., Park, Se Hoon, Agerbaek, Mads, Jha, Gautam, Stenner, Frank, Ye, Dingwei, Giudici, Fabio, Dutta, Santanu, Askelson, Margarita, Nasroulah, Federico, Zhang, Joshua |
Source: | Journal of Clinical Oncology; 1/1/2025, Vol. 43 Issue 1, p15-21, 9p |
Database: | Supplemental Index |
Be the first to leave a comment!